MARKET INTRODUCTION
Cytidine is a nucleoside molecule formed when cytosine is attached to a ribose ring (also known as a ribofuranose) via a ?-N1-glycosidic bond. Cytidine is a component of RNA.The transport of cytidine into the brain's extracellular fluid and then into neurons and glia are essential prerequisites for cytidine to be utilized in the brain.Cytidine deamination of nucleic acids underlies the diversification of Ig genes and inhibition of retroviral infection, and thus, it would appear to be vital to host defense. Activation-induced cytidinedeaminase (AID) induces the diversification of antibodies by deaminatingdeoxycytidine (C) within immunoglobulin genes. It initiates DNA lesions at immunoglobulin (Ig) loci that mediate antibody diversification. Inherited defects in AID result in hyper IgM immunodeficiency. AID also acts genome-wide, leading to cancer-driving mutations and chromosomal translocations
MARKET DYNAMICS
The cytidine market has shown a significant evolution over the forecast period. The key driving factors include the increasing research and development in pharmaceutical, biotechnology and molecular science, and genomics.Activation-induced cytidinedeaminase (AID) is known for its established role in antibody production. The increasing incidences of viral infections such as HIV (Human Immunodeficiency Virus), Human T-Cell Lymphotropic Virus (HTLV), Hepatitis B Virus (HBV), Human Herpesviruses (HHV), and many others are fuelling the market growth. Moreover, it is estimated that 2 billion people have been infected, and more than 240 million have chronic liver infections worldwide. Hepatitis B Virusinfection can cause acute and chronic liver disease, including cirrhosis and hepatocellular carcinoma. Technological advances and multiple upcoming pieces of researchare boosting the market growth. However, a high-cost investment in research and development is likely to hamper the market growth. Also, uncontrolled cytidine deamination might generate misfolded polypeptides, dominant-negative proteins, or mutations in tumor suppressor genes, and thus contribute to tumor formation, thereby restraining the cytidine market.
MARKET SCOPE
The "Cytidine Market Analysis to 2027" is a specialized and in-depth study of biotechnology in the healthcare industry, focusing on the global market trend analysis. This reportoutlines the cytidine marketwith detailed market segmentation by type, application, and end-user. The cytidine marketis expected to witness a high rise during the forecast period. The report focuses on the vital statistics on the market status of the leading players in the cytidine marketand offers key trends and opportunities.
MARKET SEGMENTATION
The market is segmented based on type, application, and end-user. Based on type, the market is categorized as cytarabine and azacitidine.Based onthe application, the market is segmented as cancer therapy and acute leukemia therapy. Based on the end-user, the market is segmented ashospitals, clinics, and others.
REGIONAL FRAMEWORK
The report lays out a comprehensive outline of the industry, including both quantitative and qualitative information. The report gives a sketch and forecast of the cytidine marketbased onvarious segments.It also consistsof market size and forecast estimates from the year 2018 to2027 concerning five major regions: North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. The marketby each region is then subdivided into respective countries and segments. The report comprises the analysis and forecast of eighteen countries globally and the recent trend and opportunities prevailing in the region.
The report analyzes factors affecting the cytidine marketfrom both the demand and supply side. Moreover, it evaluates market dynamics affecting the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends.
The report also consistsof precise PEST analysis for all five regions, namely; North America, Europe, APAC, MEA, and South & Central America, after evaluating political, economic, social, and technological factors affecting the cytidine marketin these regions.
MARKET PLAYERS
The report contains critical developments in the cytidine marketas organic and inorganic growth strategies. Various enterprisesfocuson organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies observed in the market were acquisitions and partnerships & collaborations. These activities have paved the way for the expansion of business and customer base of market players. The market players from the cytidine marketare anticipated to have profitable growth opportunities in the coming years with the rising demand for the cytidine market globally. Given below is the list of few companies engaged in the cytidine market.
The report also consists of the profiles of key players in the cytidine market, along with their SWOT analysis and market strategies. Additionally, the report elaborates on leading industry players with information on company profiles, components, and services provided, financial information of the last three years, critical development in the past five years.
- HBio (Hellenic Bio Cluster)
- Pfizer Inc.
- Amgen Inc.
- F. Hoffmann-La Roche Ltd
- BIOGEN IDEC INC.
- Cipla
- AstraZeneca
- Teva Pharmaceutical Industries Ltd.
- Sigma-Aldrich, Inc.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. PUBLISHERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cytidine Market - By Type
1.3.2 Cytidine Market - By Application
1.3.3 Cytidine Market - By End User
1.3.4 Cytidine Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CYTIDINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. CYTIDINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CYTIDINE MARKET - GLOBAL MARKET ANALYSIS
6.1. CYTIDINE - GLOBAL MARKET OVERVIEW
6.2. CYTIDINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CYTIDINE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CYTARABINE
7.3.1. Overview
7.3.2. Cytarabine Market Forecast and Analysis
7.4. AZACITIDINE
7.4.1. Overview
7.4.2. Azacitidine Market Forecast and Analysis
8. CYTIDINE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER THERAPY
8.3.1. Overview
8.3.2. Cancer Therapy Market Forecast and Analysis
8.4. ACUTE LEUKEMIA THERAPY
8.4.1. Overview
8.4.2. Acute Leukemia Therapy Market Forecast and Analysis
9. CYTIDINE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. CYTIDINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Cytidine Market Overview
10.1.2 North America Cytidine Market Forecasts and Analysis
10.1.3 North America Cytidine Market Forecasts and Analysis - By Type
10.1.4 North America Cytidine Market Forecasts and Analysis - By Application
10.1.5 North America Cytidine Market Forecasts and Analysis - By End User
10.1.6 North America Cytidine Market Forecasts and Analysis - By Countries
10.1.6.1 United States Cytidine Market
10.1.6.1.1 United States Cytidine Market by Type
10.1.6.1.2 United States Cytidine Market by Application
10.1.6.1.3 United States Cytidine Market by End User
10.1.6.2 Canada Cytidine Market
10.1.6.2.1 Canada Cytidine Market by Type
10.1.6.2.2 Canada Cytidine Market by Application
10.1.6.2.3 Canada Cytidine Market by End User
10.1.6.3 Mexico Cytidine Market
10.1.6.3.1 Mexico Cytidine Market by Type
10.1.6.3.2 Mexico Cytidine Market by Application
10.1.6.3.3 Mexico Cytidine Market by End User
10.2. EUROPE
10.2.1 Europe Cytidine Market Overview
10.2.2 Europe Cytidine Market Forecasts and Analysis
10.2.3 Europe Cytidine Market Forecasts and Analysis - By Type
10.2.4 Europe Cytidine Market Forecasts and Analysis - By Application
10.2.5 Europe Cytidine Market Forecasts and Analysis - By End User
10.2.6 Europe Cytidine Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Cytidine Market
10.2.6.1.1 Germany Cytidine Market by Type
10.2.6.1.2 Germany Cytidine Market by Application
10.2.6.1.3 Germany Cytidine Market by End User
10.2.6.2 France Cytidine Market
10.2.6.2.1 France Cytidine Market by Type
10.2.6.2.2 France Cytidine Market by Application
10.2.6.2.3 France Cytidine Market by End User
10.2.6.3 Italy Cytidine Market
10.2.6.3.1 Italy Cytidine Market by Type
10.2.6.3.2 Italy Cytidine Market by Application
10.2.6.3.3 Italy Cytidine Market by End User
10.2.6.4 Spain Cytidine Market
10.2.6.4.1 Spain Cytidine Market by Type
10.2.6.4.2 Spain Cytidine Market by Application
10.2.6.4.3 Spain Cytidine Market by End User
10.2.6.5 United Kingdom Cytidine Market
10.2.6.5.1 United Kingdom Cytidine Market by Type
10.2.6.5.2 United Kingdom Cytidine Market by Application
10.2.6.5.3 United Kingdom Cytidine Market by End User
10.2.6.6 Rest of Europe Cytidine Market
10.2.6.6.1 Rest of Europe Cytidine Market by Type
10.2.6.6.2 Rest of Europe Cytidine Market by Application
10.2.6.6.3 Rest of Europe Cytidine Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Cytidine Market Overview
10.3.2 Asia-Pacific Cytidine Market Forecasts and Analysis
10.3.3 Asia-Pacific Cytidine Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Cytidine Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Cytidine Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Cytidine Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Cytidine Market
10.3.6.1.1 Australia Cytidine Market by Type
10.3.6.1.2 Australia Cytidine Market by Application
10.3.6.1.3 Australia Cytidine Market by End User
10.3.6.2 China Cytidine Market
10.3.6.2.1 China Cytidine Market by Type
10.3.6.2.2 China Cytidine Market by Application
10.3.6.2.3 China Cytidine Market by End User
10.3.6.3 India Cytidine Market
10.3.6.3.1 India Cytidine Market by Type
10.3.6.3.2 India Cytidine Market by Application
10.3.6.3.3 India Cytidine Market by End User
10.3.6.4 Japan Cytidine Market
10.3.6.4.1 Japan Cytidine Market by Type
10.3.6.4.2 Japan Cytidine Market by Application
10.3.6.4.3 Japan Cytidine Market by End User
10.3.6.5 South Korea Cytidine Market
10.3.6.5.1 South Korea Cytidine Market by Type
10.3.6.5.2 South Korea Cytidine Market by Application
10.3.6.5.3 South Korea Cytidine Market by End User
10.3.6.6 Rest of Asia-Pacific Cytidine Market
10.3.6.6.1 Rest of Asia-Pacific Cytidine Market by Type
10.3.6.6.2 Rest of Asia-Pacific Cytidine Market by Application
10.3.6.6.3 Rest of Asia-Pacific Cytidine Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Cytidine Market Overview
10.4.2 Middle East and Africa Cytidine Market Forecasts and Analysis
10.4.3 Middle East and Africa Cytidine Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Cytidine Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Cytidine Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Cytidine Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Cytidine Market
10.4.6.1.1 South Africa Cytidine Market by Type
10.4.6.1.2 South Africa Cytidine Market by Application
10.4.6.1.3 South Africa Cytidine Market by End User
10.4.6.2 Saudi Arabia Cytidine Market
10.4.6.2.1 Saudi Arabia Cytidine Market by Type
10.4.6.2.2 Saudi Arabia Cytidine Market by Application
10.4.6.2.3 Saudi Arabia Cytidine Market by End User
10.4.6.3 U.A.E Cytidine Market
10.4.6.3.1 U.A.E Cytidine Market by Type
10.4.6.3.2 U.A.E Cytidine Market by Application
10.4.6.3.3 U.A.E Cytidine Market by End User
10.4.6.4 Rest of Middle East and Africa Cytidine Market
10.4.6.4.1 Rest of Middle East and Africa Cytidine Market by Type
10.4.6.4.2 Rest of Middle East and Africa Cytidine Market by Application
10.4.6.4.3 Rest of Middle East and Africa Cytidine Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Cytidine Market Overview
10.5.2 South and Central America Cytidine Market Forecasts and Analysis
10.5.3 South and Central America Cytidine Market Forecasts and Analysis - By Type
10.5.4 South and Central America Cytidine Market Forecasts and Analysis - By Application
10.5.5 South and Central America Cytidine Market Forecasts and Analysis - By End User
10.5.6 South and Central America Cytidine Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Cytidine Market
10.5.6.1.1 Brazil Cytidine Market by Type
10.5.6.1.2 Brazil Cytidine Market by Application
10.5.6.1.3 Brazil Cytidine Market by End User
10.5.6.2 Argentina Cytidine Market
10.5.6.2.1 Argentina Cytidine Market by Type
10.5.6.2.2 Argentina Cytidine Market by Application
10.5.6.2.3 Argentina Cytidine Market by End User
10.5.6.3 Rest of South and Central America Cytidine Market
10.5.6.3.1 Rest of South and Central America Cytidine Market by Type
10.5.6.3.2 Rest of South and Central America Cytidine Market by Application
10.5.6.3.3 Rest of South and Central America Cytidine Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CYTIDINE MARKET, KEY COMPANY PROFILES
12.1. HBIO (HELLENIC BIO CLUSTER)
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AMGEN INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. F. HOFFMANN-LA ROCHE LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BIOGEN IDEC INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CIPLA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ASTRAZENECA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SIGMA-ALDRICH, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT PUBLISHERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. HBio (Hellenic Bio Cluster)
2. Pfizer Inc.
3. Amgen Inc.
4. F. Hoffmann-La Roche Ltd
5. BIOGEN IDEC INC.
6. Cipla
7. AstraZeneca
8. Teva Pharmaceutical Industries Ltd.
9. Sigma-Aldrich, Inc.
Global Rare Hematology Market Growth Sta..
According to this study, over the next five years the Rare H..
+1-646-791 7070US (Toll Free)